ConductScience.org, home

Paper9733870

Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.

Belyakov IM and 8 others. J Virol, 1998. Cited by 101 papers, by iCite.

Cite this record

ConductScience Library. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein. Papers, record 9733870. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9733870

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
PubMed
Journal
J Virol
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
101
iCite
Relative citation ratio, by iCite
2.04
iCite
Revised in PubMed
2020-07-24
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Belyakov IMI M
2Wyatt LSL S
3Ahlers JDJ D
4Earl PP
5Pendleton CDC D
6Kelsall BLB L
7Strober WW
8Moss BB
9Berzofsky JAJ A

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
HIV Envelope Protein gp160Major topic
Immunity, MucosalMajor topic
T-Lymphocytes, CytotoxicMajor topic
Vaccines, SyntheticMajor topic
Vaccinia virusMajor topic
Animals
Cell Line
Cross Reactions
Defective Viruses
Female
Immunologic Memory
Interleukin-6
Mice
Mice, Inbred BALB C
Rectum
Tumor Necrosis Factor-alpha

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12789433A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160.Science1989https://conductscience.org/library/papers/2789433PubMed
22452443An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.Proc Natl Acad Sci U S A1988https://conductscience.org/library/papers/2452443PubMed
32685955Risks and benefits of vaccinia vaccine use in the worldwide smallpox eradication campaign.Res Virol1989https://conductscience.org/library/papers/2685955PubMed
41689366An immunodominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 class II-restricted help for itself.J Exp Med1990https://conductscience.org/library/papers/1689366PubMed
52182912Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.J Virol1990https://conductscience.org/library/papers/2182912PubMed
62033387Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence.J Gen Virol1991https://conductscience.org/library/papers/2033387PubMed
72047875Vaccinia virus: a tool for research and vaccine development.Science1991https://conductscience.org/library/papers/2047875PubMed
81371784Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.J Immunol1992https://conductscience.org/library/papers/1371784PubMed
91316930Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules.J Exp Med1992https://conductscience.org/library/papers/1316930PubMed
101512047Cells and cytokines in mucosal immunity and inflammation.Gastroenterol Clin North Am1992https://conductscience.org/library/papers/1512047PubMed
111438287Nonreplicating vaccinia vector efficiently expresses recombinant genes.Proc Natl Acad Sci U S A1992https://conductscience.org/library/papers/1438287PubMed
128421498Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin.Nature1993https://conductscience.org/library/papers/8421498PubMed
138245770H-2Dd exploits a four residue peptide binding motif.J Exp Med1993https://conductscience.org/library/papers/8245770PubMed
147975844A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.Vaccine1994https://conductscience.org/library/papers/7975844PubMed
157530749Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.J Immunol1995https://conductscience.org/library/papers/7530749PubMed
168648709
Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara.
J Virol1996https://conductscience.org/library/papers/8648709PubMed
178673922Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques.Nat Med1996https://conductscience.org/library/papers/8673922PubMed
188674120A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.Cell1996https://conductscience.org/library/papers/8674120PubMed
198709274Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.J Virol1996https://conductscience.org/library/papers/8709274PubMed
208760802Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL.J Exp Med1996https://conductscience.org/library/papers/8760802PubMed

See all 35 referencesDownload CSV of references

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.

PMIDTitleJournalYearIn PapersSource
36679860Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice.Vaccines (Basel)2022https://conductscience.org/library/papers/36679860PubMed
33072113A Systemic Prime-Intrarectal Pull Strategy Raises Rectum-Resident CD8+ T Cells for Effective Protection in a Murine Model of LM-OVA Infection.Front Immunol2020https://conductscience.org/library/papers/33072113PubMed
29374075Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.J Immunol2018https://conductscience.org/library/papers/29374075PubMed
29257056
Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins.
Vaccines (Basel)2017https://conductscience.org/library/papers/29257056PubMed
28056224Recombinant fowlpox virus vector-based vaccines: expression kinetics, dissemination and safety profile following intranasal delivery.J Gen Virol2017https://conductscience.org/library/papers/28056224PubMed
26523292New prospects for a preventive HIV-1 vaccine.J Virus Erad2015https://conductscience.org/library/papers/26523292PubMed
23666811Nasal delivery of PLG microparticle encapsulated defensin peptides adjuvanted gp41 antigen confers strong and long-lasting immunoprotective response against HIV-1.Immunol Res2014https://conductscience.org/library/papers/23666811PubMed
22038530GUCY2C-targeted cancer immunotherapy: past, present and future.Immunol Res2011https://conductscience.org/library/papers/22038530PubMed
21928282Lack of IL-7 and IL-15 signaling affects interferon-γ production by, more than survival of, small intestinal intraepithelial memory CD8+ T cells.Eur J Immunol2011https://conductscience.org/library/papers/21928282PubMed
20624114Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.Expert Opin Biol Ther2010https://conductscience.org/library/papers/20624114PubMed
20122733Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.Leuk Res2010https://conductscience.org/library/papers/20122733PubMed
20045097One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.Vaccine2010https://conductscience.org/library/papers/20045097PubMed
19571797Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa.Mucosal Immunol2009https://conductscience.org/library/papers/19571797PubMed
19159014A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination.PLoS One2009https://conductscience.org/library/papers/19159014PubMed
18796634The IL-15 receptor {alpha} chain cytoplasmic domain is critical for normal IL-15Ralpha function but is not required for trans-presentation.Blood2008https://conductscience.org/library/papers/18796634PubMed
18793787Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.Virology2008https://conductscience.org/library/papers/18793787PubMed
18412969Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivo.BMC Immunol2008https://conductscience.org/library/papers/18412969PubMed
18048074Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.Virology2008https://conductscience.org/library/papers/18048074PubMed
17706843HIV-1(89.6) Gag expressed from a replication competent HSV-1 vector elicits persistent cellular immune responses in mice.Vaccine2007https://conductscience.org/library/papers/17706843PubMed
17170437Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.J Gen Virol2007https://conductscience.org/library/papers/17170437PubMed

See all 42 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ENPEP2028PubTator's text mininghttps://conductscience.org/library/genes/2028

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9733870

GET https://conductscience.org/api/papers/v1/9733870/references?page=2